TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ImmunoIVD AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
4,437
|
3,807
|
3,452 |
Financial expenses |
152
|
142
|
130 |
Earnings before taxes |
397
|
500
|
-276 |
EBITDA |
723
|
861
|
53 |
Total assets |
2,964
|
2,807
|
2,464 |
Current assets |
2,403
|
2,253
|
1,728 |
Current liabilities |
2,237
|
2,168
|
2,451 |
Equity capital |
727
|
639
|
13 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
25
|
23
|
26 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
24.5%
|
22.8%
|
0.5% |
Turnover per employee |
177
|
166
|
133 |
Profit as a percentage of turnover |
8.9%
|
13.1%
|
-8.0% |
Return on assets (ROA) |
18.5%
|
22.9%
|
-5.9% |
Current ratio |
107.4%
|
103.9%
|
70.5% |
Return on equity (ROE) |
54.6%
|
78.2%
|
-2123.1% |
Change turnover |
619
|
635
|
1,315 |
Change turnover % |
16%
|
20%
|
61% |
Chg. No. of employees |
2
|
-3
|
5 |
Chg. No. of employees % |
9%
|
-12%
|
24% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.